Kim A. Neve

Professor of Behavioral Neuroscience Research Pharmacologist Behavioral Neuroscience Graduate Program Neuroscience Graduate Program

Oregon Health & Science University

Affiliations

Division Of Neuroscience

Oregon Health & Science University

Kim A. Neve is currently serving as a Division Of Neuroscience Professor of Behavioral Neuroscience Research Pharmacologist Behavioral Neuroscience Graduate Program Neuroscience Graduate Program at Oregon Health & Science University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Kim A. Neve

Oregon Health & Science University

Professor of Behavioral Neuroscience Research Pharmacologist Behavioral Neuroscience Graduate Program Neuroscience Graduate Program

You can click a keyword to filter the displayed items

neuroscience pharmacology dopamine receptors neuropharmacology neuropsychopharmacology signal transduction molecular biology molecular pharmacology cell signaling neurochemistry genetics gene expression neurons receptor (biochemistry) pharmacological research neurotransmission drug discovery molecular neurodegeneration g protein-coupled receptor biological chemistry addiction biology enzyme inhibition protein science adenylate cyclase medicinal research mammalian biology molecular physiology molecular psychiatry psychopharmacology neurotransmitters enzyme specificity pharmacotherapy experimental medicine molecular neurobiology translational pharmacology experimental pharmacology gene function adenylyl cyclase molecular cloning neostriatal neurons selective activation agonist affinities comfa-based prediction dopamine receptors peptides applied pharmacology cellular physiology release mechanism inhibitory activity neuropeptide receptors rna biology cell regulation neuroendocrine disorders cell trafficking intracellular trafficking genetic predisposition genotype-phenotype association cellular pharmacology gene transfer neuromodulation (medicine) cellular neurobiology brain function connectomics behavioural pharmacology virus-host interactions antiviral responses substance addiction prolactin secretion brain disorders recombinant adenylate cyclase structural analogs pharmacological evaluation computer-assisted video analysis arrestin recruitment incentive motivation developmental system protein structure nervous system molecular informatics behavioral neuroscience biochemistry cell biology proteome research chemical biology molecular cell biology developmental neurobiology psychoneuroendocrinology biomolecular structure central nervous system structural biology biochemical sciences neuroanatomy biological psychiatry neural circuits neurogenetics molecular and cellular biology molecular neuroscience systems neuroscience developmental biology cellular biochemistry physiology biophysics systems biology pineal research structural molecular biology neurophysiology

Notable Scholarly Works

Notable Federal Grants

Collaborators

Comparison of the Function of Two Novel Human Dopamine D2 Receptor Variants Identifies a Likely Mechanism for Their Pathogenicity (Abstract Id: 167035). Journal of Pharmacology and Experimental Therapeutics (2025)

receptorsmolecular psychiatryparkinson's diseaselikely mechanismneurosciencepathogenesismolecular neurodegenerationabstract idimmunologyneuropharmacologydopamineneurodegenerative diseasespsychiatric genetics

Dopamine Receptors in Gtopdb V.2025.3. IUPHAR/BPS Guide to Pharmacology CITE (2025)

Mice Carrying the Human Dopamine D2 Receptor Pathogenic Mutation P.Met374Arg Exhibit Hyperactivity and Aberrant D2 Receptor Function. Molecular Pharmacology (2025)

pharmacologyreceptorsmolecular psychiatryneurogeneticsneurosciencefunctional selectivityneuropsychopharmacologymolecular neurosciencedopamine

Gait Abnormalities and Aberrant D2 Receptor Expression and Signaling in a Mouse Model of the Human Pathogenic Mutation Drd2 I212f. bioRxiv (Cold Spring Harbor Laboratory) (2022)

mouse modelreceptorsmolecular cell biologygene functionsignal transductionneurogeneticsmolecular medicineknockout micemolecular neurodegenerationmolecular physiologydevelopmental biologycell signalinggait abnormalitiescell biologymolecular and cellular biologymammalian biology

Gait Abnormalities and Aberrant D2 Receptor Expression and Signaling in Mice Carrying the Human Pathogenic Mutation Drd2. Molecular Pharmacology (2022)

neurogeneticsmolecular medicinedevelopmental biologycell signalinggait abnormalitiescell biology

Tyrphostin A9 Protects Axons in Experimental Autoimmune Encephalomyelitis Through Activation of Erks. Life Sciences (2022)

neurosciencecell deathmolecular neurodegenerationautoantibody productionimmunologyautoimmune diseasescell biologyexperimental medicineautoimmunity

A Novel Variant of the Human Dopamine D2 Receptor, Associated With a Hyperkinetic Movement Disorder, Mediates Enhanced Activation of G Proteins. The FASEB Journal (2021)

pharmacologynovel variantreceptorshyperkinetic movement disorderg proteinsmuscular dystrophiesneurosciencefunctional selectivityneuropsychopharmacologyg protein-coupled receptorneuropharmacologydopaminemovement disorders

Characterization of a D1 Dopamine Receptor Positive Allosteric Modulator With a Novel Binding Site. The FASEB Journal (2021)

K LudermanRB FreeF KoenigsbergJ AubeK FrankowskiK Neve...

pharmacologyreceptorsneuroscienceneuropharmacologydopaminenovel binding site

Commentary on “Novel Interaction of the Dopamine D2 Receptor and the Ca2+ Binding Protein S100B: Role in D2 Receptor Function”. Molecular Pharmacology (2021)

Reply to: “Childhood Onset Chorea Caused by a Recurrent De Novo Drd2 Variant”. Movement Disorders (2021)